Table 1.
Biophysical characteristics of WT and R56Q mutant channels in the absence and presence of RPR260243 (RPR) at 21°C and 37°C
RPRActivationDeactivation (at −110 mV for 21°C, at −60 mV for 37°C)InactivationInactivation recovery
V1/2 (mV)k (mV)τfast (ms)τslow (ms)% AfastV1/2 (mV)k (mV)τ-90mV (ms)
21°C WT Ctrl −11.9 ± 2.8 10.3 ± 0.8 36.4 ± 10.6 166.8 ± 134 81 ± 5.9 −55.8 ± 6.1 −19.2 ± 0.9 8.8 ± 3.7 
1 µM 36.2 ± 5.9 182.8 ± 54 83 ± 4.4 
3 µM 28.5 ± 7.8 221.7 ± 102 86 ± 2.7 
10 µM −14.1 ± 3.4a 10.6 ± 0.7 40.9 ± 3.1 953.7 ± 252a 79 ± 4.6 −44.0 ± 6.6a −17.6 ± 0.8 4.2 ± 1.3 
R56Q Ctrl −10.5 ± 2.7 10.5 ± 0.3 15.7 ± 1.6b 114.0 ± 20.9b 94 ± 2.7b −41.5 ± 8.5b −19.6 ± 2.3 5.5 ± 2.3 
 1 µM 14.9 ± 0.4 166.6 ± 30.1 95 ± 0.8 
3 µM 17.2 ± 1.8 188.0 ± 31.4 89 ± 1.5 
10 µM −12.3 ± 3.2a 10.7 ± 0.6 20.1 ± 0.9 223.2 ± 16.1 85 ± 1.9a −40.5 ± 8.3 −20.4 ± 1.6 6.3 ± 2.7 
37°C WT Ctrl −25.8 ± 3.1 6.2 ± 0.6 161 ± 43 866.8 ± 288 55 ± 7.3 −34.3 ± 10.4 −20.0 ± 0.5 1.5 ± 0.3 
1 µM 162 ± 24 1,595 ± 124 40 ± 6.3a 
3 µM 129 ± 35 2,526 ± 231 20 ± 4.8a 
10 µM −26.5 ± 3.4 5.9 ± 0.7 54.9 ± 14a 6,029 ± 2,699a 7.2 ± 3.9a −27.1 ± 6.8 −19.3 ± 1.7 1.6 ± 0.3 
R56Q Ctrl −15.8 ± 3.9b 7.9 ± 2.3 43.5 ± 5.1b 539.8 ± 322 93 ± 5.7b −10.9 ± 16.9b −19.9 ± 2.1 1.4 ± 1.1 
1 µM 50.2 ± 8.2 1,440 ± 276 74 ± 4.3a 
3 µM 59.8 ± 8.5 1,850 ± 432 51 ± 5.7a 
10 µM −21.5 ± 6.0a 7.1 ± 1.6 46.0 ± 10 1,520 ± 533 37 ± 10.5a −15.0 ± 14.7 −17.8 ± 4.4 1.7 ± 1.4 
RPRActivationDeactivation (at −110 mV for 21°C, at −60 mV for 37°C)InactivationInactivation recovery
V1/2 (mV)k (mV)τfast (ms)τslow (ms)% AfastV1/2 (mV)k (mV)τ-90mV (ms)
21°C WT Ctrl −11.9 ± 2.8 10.3 ± 0.8 36.4 ± 10.6 166.8 ± 134 81 ± 5.9 −55.8 ± 6.1 −19.2 ± 0.9 8.8 ± 3.7 
1 µM 36.2 ± 5.9 182.8 ± 54 83 ± 4.4 
3 µM 28.5 ± 7.8 221.7 ± 102 86 ± 2.7 
10 µM −14.1 ± 3.4a 10.6 ± 0.7 40.9 ± 3.1 953.7 ± 252a 79 ± 4.6 −44.0 ± 6.6a −17.6 ± 0.8 4.2 ± 1.3 
R56Q Ctrl −10.5 ± 2.7 10.5 ± 0.3 15.7 ± 1.6b 114.0 ± 20.9b 94 ± 2.7b −41.5 ± 8.5b −19.6 ± 2.3 5.5 ± 2.3 
 1 µM 14.9 ± 0.4 166.6 ± 30.1 95 ± 0.8 
3 µM 17.2 ± 1.8 188.0 ± 31.4 89 ± 1.5 
10 µM −12.3 ± 3.2a 10.7 ± 0.6 20.1 ± 0.9 223.2 ± 16.1 85 ± 1.9a −40.5 ± 8.3 −20.4 ± 1.6 6.3 ± 2.7 
37°C WT Ctrl −25.8 ± 3.1 6.2 ± 0.6 161 ± 43 866.8 ± 288 55 ± 7.3 −34.3 ± 10.4 −20.0 ± 0.5 1.5 ± 0.3 
1 µM 162 ± 24 1,595 ± 124 40 ± 6.3a 
3 µM 129 ± 35 2,526 ± 231 20 ± 4.8a 
10 µM −26.5 ± 3.4 5.9 ± 0.7 54.9 ± 14a 6,029 ± 2,699a 7.2 ± 3.9a −27.1 ± 6.8 −19.3 ± 1.7 1.6 ± 0.3 
R56Q Ctrl −15.8 ± 3.9b 7.9 ± 2.3 43.5 ± 5.1b 539.8 ± 322 93 ± 5.7b −10.9 ± 16.9b −19.9 ± 2.1 1.4 ± 1.1 
1 µM 50.2 ± 8.2 1,440 ± 276 74 ± 4.3a 
3 µM 59.8 ± 8.5 1,850 ± 432 51 ± 5.7a 
10 µM −21.5 ± 6.0a 7.1 ± 1.6 46.0 ± 10 1,520 ± 533 37 ± 10.5a −15.0 ± 14.7 −17.8 ± 4.4 1.7 ± 1.4 

Ctrl, control.

a

Significant difference compared to control (drug versus control).

b

Significant difference compared to construct (R56Q versus WT).

or Create an Account

Close Modal
Close Modal